{"organizations": [], "uuid": "613901a5b952014498501382c8458e5c7386ef48", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-cumberland-pharma-says-data-demons/brief-cumberland-pharma-says-data-demonstrates-amifostine-reduces-gastro-intestinal-toxicity-for-multiple-myeloma-patients-idUSFWN1PP18P", "country": "US", "domain_rank": 408, "title": "BRIEF-Cumberland Pharma Says Data Demonstrates Amifostine Reduces Gastro-Intestinal Toxicity For Multiple Myeloma Patients", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-30T17:49:00.000+02:00", "replies_count": 0, "uuid": "613901a5b952014498501382c8458e5c7386ef48"}, "author": "", "url": "https://www.reuters.com/article/brief-cumberland-pharma-says-data-demons/brief-cumberland-pharma-says-data-demonstrates-amifostine-reduces-gastro-intestinal-toxicity-for-multiple-myeloma-patients-idUSFWN1PP18P", "ord_in_thread": 0, "title": "BRIEF-Cumberland Pharma Says Data Demonstrates Amifostine Reduces Gastro-Intestinal Toxicity For Multiple Myeloma Patients", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-cumberland pharma says data", "sentiment": "negative"}, {"name": "brief-cumberland pharma says data demonstrates amifostine", "sentiment": "negative"}, {"name": "cumberland pharmaceuticals inc", "sentiment": "none"}, {"name": "multiple myeloma patients reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 30, 2018 / 3:49 PM / in 13 minutes BRIEF-Cumberland Pharma Says Data Demonstrates Amifostine Reduces Gastro-Intestinal Toxicity For Multiple Myeloma Patients Reuters Staff 1 Min Read \nJan 30 (Reuters) - Cumberland Pharmaceuticals Inc: \n* CUMBERLAND PHARMACEUTICALS INC - NEWLY PUBLISHED DATA DEMONSTRATES AMIFOSTINE REDUCES GASTRO-INTESTINAL TOXICITY FOR MULTIPLE MYELOMA PATIENTS Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-30T17:49:00.000+02:00", "crawled": "2018-01-30T18:17:19.007+02:00", "highlightTitle": ""}